The evaluation of the request of the applicant to amend the condition of approval cannot be considered as a review of the approval of 8-hydroxyquinoline. Therefore the conditions of approval of the active substance 8-hydroxyquinoline, as set out in row 18 of Part B of the Annex to Implementing Regulation (EU) No 540/2011, should remain unchanged, and be confirmed.
Recital 11, Regulation (EU) 2017/2065
In forcesince 13 Nov 2017cited 1×
Judgment of the General Court (Fifth Chamber) of 19 December 2019. Probelte, SA v European Commission.Decision
First of all, 8‑hydroxyquinoline was classed as toxic for reproduction category 1B under Regulation 2017/776 (see paragraph 12 above), which, according to point 3.6.4 of Annex II to Regulation No 1107/2009, precludes, in principle, the …
19 Dec 2019 · 62018TJ0067